Since 2007 the World Health Organization (WHO) and the Joint United Nations
Programme on HIV/AIDS (UNAIDS) have recommended voluntary medical male
circumcision (VMMC) as an important strategy for the prevention of heterosexually
acquired HIV in men in settings where the prevalence of heterosexually trans...
WHO estimates that in 2015, 257 million people were living with chronic hepatitis B
virus (HBV) infection worldwide, and that 900 000 had died from HBV infection, mostly
as a result of cirrhosis or hepatocellular carcinoma. Most HBV-associated deaths among
adults are secondary to infections acquired at b...
Since its identification in China in December 2019, the novel coronavirus COVID-19 has rapidly evolved into a pandemic. COVID-19 manifests with non-specific respiratory symptoms of variable severity and may require advanced respiratory support. The diagnosis of COVID-19 is currently confirmed by laborato...
This document provides rapid advice on the use of medical masks in communities, at home and at healthcare facilities in areas that have reported outbreaks caused by the 2019 novel coronavirus (2019-nCoV). It is intended for public health and infection prevention and control (IPC) professionals, healthcar...
In the health sector response to the HIV epidemic, collection, analysis and use of data are
crucial at every level, from patient care and monitoring through programme management and
national programme monitoring to global monitoring. This strategic information answers the
questions: “How are patients d...
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people livin...
The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing of patients who meet the definition of suspected case of pneumonia associated with a novel coronavirus identified in Wuhan, China....
This is the first edition of guidance on infection prevention and control (IPC) strategies for use when infection with a novel coronavirus (2019-nCoV) is suspected. It has been adapted from WHO’s Infection prevention and control during health care for probable or confirmed cases of Middle East respirat...
WHO has developed this interim guidance to meet the need
for recommendations on safe home care for patients with
suspected COVID-19 who present with mild symptoms
a
and
on public health measures related to the management of their
contacts.
This document was adapted from the interim guidance on
Middle Eas...
This document is intended for clinicians taking care of hospitalised adult and paediatric patients with severe acute respiratory infection (SARI) when a nCoV infection is suspected. It is not meant to replace clinical judgment or specialist consultation but rather to strengthen clinical management of the...
